Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.

Lee, Myung-Ah; Byun, Jae-Ho; Shim, Byoung-Young; Woo, In-Sook; Kang, Jin-Hyung; Hong, Young Seon; Lee, Kyung Shik; Choi, Myung Gyu; Chang, Suk Kyun; Oh, Seong Taek; Choi, Sung Il; Lee, Doo Suk

Lee, Myung-Ah; Byun, Jae-Ho; Shim, Byoung-Young; Woo, In-Sook; Kang, Jin-Hyung; Hong, Young Seon; Lee, Kyung Shik; Choi, Myung Gyu; Chang, Suk Kyun; Oh, Seong Taek; Choi, Sung Il; Lee, Doo Suk.

Affiliation

Lee MA; Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

Korean J Intern Med ; 20(3): 205-9, 2005 Sep.

Article in En | MEDLINE | ID: mdl-16295778

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Colorectal Neoplasms/drug therapy; Neoplasm Metastasis/drug therapy; Neoplasm Recurrence, Local/drug therapy; Adult; Aged; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Colorectal Neoplasms/pathology; Disease Progression; Female; Fluorouracil/administration & dosage; Humans; Irinotecan; Leucovorin/administration & dosage; Male; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Metastasis / Neoplasm Recurrence, Local Language: En Journal: Korean J Intern Med Year: 2005 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google